1096 related articles for article (PubMed ID: 17056094)
21. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
[TBL] [Abstract][Full Text] [Related]
22. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
Pan CC; Chen PC; Ho DM
Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
[TBL] [Abstract][Full Text] [Related]
23. Oncocytic papillary renal cell carcinoma with solid architecture: mimic of renal oncocytoma.
Mai KT; Kohler DM; Robertson SJ; Belanger EC; Marginean EC
Pathol Int; 2008 Mar; 58(3):164-8. PubMed ID: 18251779
[TBL] [Abstract][Full Text] [Related]
24. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.
Sengupta S; Lohse CM; Leibovich BC; Frank I; Thompson RH; Webster WS; Zincke H; Blute ML; Cheville JC; Kwon ED
Cancer; 2005 Aug; 104(3):511-20. PubMed ID: 15973740
[TBL] [Abstract][Full Text] [Related]
25. [Adult renal neoplasms in the material of the Pathology Department of the Szeged University].
Németh I; Sükösd F; Béli L; Kiss A; Pajor L; Mikó T; Iványi B
Orv Hetil; 2005 Apr; 146(14):653-8. PubMed ID: 15889540
[TBL] [Abstract][Full Text] [Related]
26. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M
Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity of DNA repair gene, hOGG1, in renal cell carcinoma but not in renal papillary adenoma.
Gokden N; Li L; Zhang H; Schafer RF; Schichman S; Scott MA; Smoller BR; Fan CY
Pathol Int; 2008 Jun; 58(6):339-43. PubMed ID: 18477212
[TBL] [Abstract][Full Text] [Related]
28. Renal-cell carcinomas in end-stage kidneys: a clinicopathological study with emphasis on clear-cell papillary renal-cell carcinoma and acquired cystic kidney disease-associated carcinoma.
Bhatnagar R; Alexiev BA
Int J Surg Pathol; 2012 Feb; 20(1):19-28. PubMed ID: 21791489
[TBL] [Abstract][Full Text] [Related]
29. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity.
Gobbo S; Eble JN; Grignon DJ; Martignoni G; MacLennan GT; Shah RB; Zhang S; Brunelli M; Cheng L
Am J Surg Pathol; 2008 Aug; 32(8):1239-45. PubMed ID: 18594469
[TBL] [Abstract][Full Text] [Related]
30. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
Khurana KK; Truong LD; Verani RR
Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
[TBL] [Abstract][Full Text] [Related]
31. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma.
Olgac S; Hutchinson B; Tickoo SK; Reuter VE
Mod Pathol; 2006 Feb; 19(2):218-24. PubMed ID: 16424894
[TBL] [Abstract][Full Text] [Related]
32. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
33. Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study.
Breda A; Treat EG; Haft-Candell L; Leppert JT; Harper JD; Said J; Raman S; Smith RB; Belldegrun AS; Schulam PG
BJU Int; 2010 Apr; 105(7):940-5. PubMed ID: 19888984
[TBL] [Abstract][Full Text] [Related]
34. Multicentric papillary renal cell carcinoma associated with renal adenomatosis.
Kiyoshima K; Oda Y; Nakamura T; Migita T; Okumura K; Naito S; Tsuneyoshi M
Pathol Int; 2004 Apr; 54(4):266-72. PubMed ID: 15028029
[TBL] [Abstract][Full Text] [Related]
35. Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases.
Hes O; Brunelli M; Michal M; Cossu Rocca P; Hora M; Chilosi M; Mina M; Boudova L; Menestrina F; Martignoni G
Ann Diagn Pathol; 2006 Jun; 10(3):133-9. PubMed ID: 16730306
[TBL] [Abstract][Full Text] [Related]
36. Expression of vitamin D3 receptor in kidney tumors.
Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
[TBL] [Abstract][Full Text] [Related]
37. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma.
Kattar MM; Grignon DJ; Wallis T; Haas GP; Sakr WA; Pontes JE; Visscher DW
Mod Pathol; 1997 Nov; 10(11):1143-50. PubMed ID: 9388066
[TBL] [Abstract][Full Text] [Related]
39. [Multicentricity and concomitant tumors in renal cell carcinoma: analysis by serial section of resected kidneys].
Saiki S; Kinouchi T; Meguro N; Maeda O; Kuroda M; Usami M; Kotake T
Hinyokika Kiyo; 1995 Sep; 41(9):725-9. PubMed ID: 7484540
[TBL] [Abstract][Full Text] [Related]
40. Pathologic spectrum of cysts in end-stage kidneys: possible precursors to renal neoplasia.
Hosseini M; Antic T; Paner GP; Chang A
Hum Pathol; 2014 Jul; 45(7):1406-13. PubMed ID: 24775605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
